V.O. Rotimi

1.3k total citations
41 papers, 1.0k citations indexed

About

V.O. Rotimi is a scholar working on Molecular Medicine, Clinical Biochemistry and Epidemiology. According to data from OpenAlex, V.O. Rotimi has authored 41 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Medicine, 14 papers in Clinical Biochemistry and 13 papers in Epidemiology. Recurrent topics in V.O. Rotimi's work include Antibiotic Resistance in Bacteria (15 papers), Bacterial Identification and Susceptibility Testing (14 papers) and Antibiotic Use and Resistance (6 papers). V.O. Rotimi is often cited by papers focused on Antibiotic Resistance in Bacteria (15 papers), Bacterial Identification and Susceptibility Testing (14 papers) and Antibiotic Use and Resistance (6 papers). V.O. Rotimi collaborates with scholars based in Kuwait, Nigeria and United Kingdom. V.O. Rotimi's co-authors include B. I. Duerden, Noura Al‐Sweih, Wafaa Jamal, Eiman Mokaddas, S. C. Sanyal, Mousa Khoursheed, Jon Brazier, Mojtaba Shahin, Salwa K. Abd–El–Hafiz and Tibor Pál and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, Journal of Clinical Pathology and Clinical Microbiology and Infection.

In The Last Decade

V.O. Rotimi

40 papers receiving 921 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V.O. Rotimi Kuwait 17 289 269 222 203 155 41 1.0k
Cheng-Hsun Chiu Taiwan 18 245 0.8× 274 1.0× 334 1.5× 142 0.7× 256 1.7× 47 1.0k
Agnieszka Chmielarczyk Poland 18 265 0.9× 305 1.1× 404 1.8× 138 0.7× 168 1.1× 59 1.1k
C. E. Nord Sweden 25 217 0.8× 383 1.4× 400 1.8× 99 0.5× 320 2.1× 74 1.5k
Ragini Macaden India 20 331 1.1× 469 1.7× 149 0.7× 195 1.0× 237 1.5× 46 1.0k
Frédérique Randrianirina Madagascar 20 512 1.8× 379 1.4× 247 1.1× 291 1.4× 320 2.1× 32 1.0k
D Dzierżanowska Poland 18 229 0.8× 504 1.9× 217 1.0× 104 0.5× 416 2.7× 85 1.4k
Marit Gjerde Tellevik Norway 14 380 1.3× 211 0.8× 82 0.4× 228 1.1× 229 1.5× 25 830
Franco Paradisi Italy 19 594 2.1× 202 0.8× 170 0.8× 230 1.1× 284 1.8× 33 1.2k
Akbar Mirsalehian Iran 24 586 2.0× 269 1.0× 390 1.8× 365 1.8× 274 1.8× 60 1.4k
Neriman Balaban Türkiye 17 256 0.9× 204 0.8× 82 0.4× 123 0.6× 337 2.2× 27 923

Countries citing papers authored by V.O. Rotimi

Since Specialization
Citations

This map shows the geographic impact of V.O. Rotimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V.O. Rotimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V.O. Rotimi more than expected).

Fields of papers citing papers by V.O. Rotimi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V.O. Rotimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V.O. Rotimi. The network helps show where V.O. Rotimi may publish in the future.

Co-authorship network of co-authors of V.O. Rotimi

This figure shows the co-authorship network connecting the top 25 collaborators of V.O. Rotimi. A scholar is included among the top collaborators of V.O. Rotimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V.O. Rotimi. V.O. Rotimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jamal, Wafaa, et al.. (2020). Prevalence of target anaerobes associated with chronic periodontitis. Access Microbiology. 2(12). acmi000177–acmi000177. 5 indexed citations
3.
Al‐Sweih, Noura, et al.. (2012). Three distinct clones of carbapenem-resistant Acinetobacter baumannii with high diversity of carbapenemases isolated from patients in two hospitals in Kuwait. Journal of Infection and Public Health. 5(1). 102–108. 37 indexed citations
4.
Rotimi, V.O., et al.. (2011). An outbreak of CTX-M-15-producing Klebsiella pneumoniae isolates in an intensive care unit of a teaching hospital in Kuwait. Indian Journal of Medical Microbiology. 29(2). 130–135. 12 indexed citations
5.
Rotimi, V.O., et al.. (2011). Sequence Analysis of <i>bla</i><sub>CTX-M</sub> Genes Carried by Clinically Significant <i>Escherichia coli</i> Isolates in Kuwait Hospitals. Medical Principles and Practice. 20(3). 213–219. 16 indexed citations
6.
Al‐Sweih, Noura, et al.. (2011). Emergence of Tigecycline and Colistin Resistance inAcinetobacterSpecies Isolated from Patients in Kuwait Hospitals. Journal of Chemotherapy. 23(1). 13–16. 64 indexed citations
7.
Salama, Mona F., et al.. (2009). Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit. Journal of Hospital Infection. 72(3). 234–242. 26 indexed citations
8.
Jamal, Wafaa, Mojtaba Shahin, & V.O. Rotimi. (2009). Surveillance and trends of antimicrobial resistance among clinical isolates of anaerobes in Kuwait hospitals from 2002 to 2007. Anaerobe. 16(1). 1–5. 25 indexed citations
10.
Salako, Nathanael, et al.. (2004). The Bacteriology of the Supragingival Plaque of Child Dental Patients in Kuwait. Medical Principles and Practice. 13(4). 191–195. 7 indexed citations
11.
Jamal, Wafaa, et al.. (2003). Comparative Evaluation of Anoxomat and Conventional Anaerobic GasPak Jar Systems for the Isolation of Anaerobic Bacteria. Medical Principles and Practice. 12(2). 81–86. 12 indexed citations
12.
Panigrahi, D., et al.. (2001). The Anaerobic Bacteriology of Intrapulmonary Infections in Kuwait. Medical Principles and Practice. 10(2). 102–105. 1 indexed citations
13.
Rotimi, V.O., et al.. (2000). An experimental mouse model to study the pathogenicity of Prevotella bivia and investigations of possible virulence.. PubMed. 49(1). 20–6. 4 indexed citations
14.
Rotimi, V.O., et al.. (2000). Influence of Five Antianaerobic Antibiotics on Endotoxin Liberation by Gram-Negative Anaerobes. Journal of Chemotherapy. 12(1). 40–47. 8 indexed citations
15.
Rotimi, V.O., et al.. (1999). Bacteroides species highly resistant to metronidazole: an emerging clinical problem?. Clinical Microbiology and Infection. 5(3). 166–169. 50 indexed citations
16.
Jamal, Wafaa, et al.. (1998). Prevalence and Susceptibility of Shigella Species to 11 Antibiotics in a Kuwait Teaching Hospital. Journal of Chemotherapy. 10(4). 285–290. 14 indexed citations
17.
Mokaddas, Eiman, V.O. Rotimi, & S. C. Sanyal. (1998). In VitroActivity of Piperacillin/Tazobactam Versus Other Broad-Spectrum Antibiotics Against Nosocomial Gram-Negative Pathogens Isolated from Burn Patients. Journal of Chemotherapy. 10(3). 208–214. 33 indexed citations
18.
Rotimi, V.O., et al.. (1996). Antibiotic Susceptibility of Clinical Isolates ofPrevotella biviain Lagos, Nigeria. Journal of Chemotherapy. 8(1). 47–51. 3 indexed citations
19.
Rotimi, V.O., et al.. (1994). A study of the aetiological agents of childhood diarrhoea in Lagos, Nigeria. Journal of Medical Microbiology. 40(1). 10–14. 106 indexed citations
20.
Ademiluyi, S. A., et al.. (1988). The anaerobic and aerobic bacterial flora of leg ulcers in patients with sickle-cell disease. Journal of Infection. 17(2). 115–120. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026